Our regulatory expertise and strategic partnerships with logistics specialists allow us to distribute product to over 100 countries worldwide. We provide expertise in global customs clearance processes and ensure complete product control and visibility during transit, resulting in reduced risk of product diversion. Simply put, we have the experience and capability to distribute your product in an expedited and secure manner. We can further support your distribution needs through product billing, invoicing and payment collection.
We have Wholesale Distribution Licenses (WDAs), which allow us to source and sell prescription drugs, globally. We also have Home Office and DEA controlled substance licenses, which allow us to source and distribute Schedule II-V controlled substances, globally. Additionally, our UK facility has a Manufacturers “Specials” License providing us with the ability to carry out secondary packaging activities including over-labeling.
Good Manufacturing Practice Standards
The FDA’s regulatory standards for the pharmaceutical industry are referred to as Good Manufacturing Practice Standards (GMPs). All sourcing and distribution of drugs at WEP Clinical is done under the strict guidelines of Good Distribution Practice (GDP) and Good Warehousing Practice (GWP). WEP Clinical has also created a robust Quality Management System (QMS) which includes approved guidelines, policies, and procedures that govern all company processes and procedures.